Matthias Ritgen, MD

Department of Internal Medicine II, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany, Germany

n/a

Poster(s):

• 1104 - A Multi-Gene Expression-Based Prognostic Model for Risk Stratification in Chronic Lymphocytic Leukemia (CLL)

• 1418 - A Refined Continuous Individualized Risk Index (CIRI2-CLL) for Accurately Predicting Outcomes after Limited-Duration CLL Therapy